{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T02:27:52Z","timestamp":1786933672038,"version":"build-2736575974"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T00:00:00Z","timestamp":1482796800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00228-016-2183-1","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T14:36:24Z","timestamp":1482849384000},"page":"399-407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Role of miRNA and its potential as a novel diagnostic biomarker in drug-induced liver injury"],"prefix":"10.1007","volume":"73","author":[{"given":"Sukumaran","family":"Sanjay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1777-5120","authenticated-orcid":false,"given":"Chandrashekaran","family":"Girish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,27]]},"reference":[{"key":"2183_CR1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mayocp.2013.09.016","volume":"89","author":"MD Leise","year":"2014","unstructured":"Leise MD, Poterucha JJ, Talwalkar JA (2014) Drug-induced liver injury. Mayo Clin Proc 89:95\u2013106","journal-title":"Mayo Clin Proc"},{"key":"2183_CR2","first-page":"198","volume":"28","author":"LM Grant","year":"2012","unstructured":"Grant LM, Rockey DC (2012) Drug-induced liver injury. Curr. Opin. Gastroenterol 28:198\u2013202","journal-title":"Gastroenterol"},{"key":"2183_CR3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrd3408","volume":"1","author":"BK Park","year":"2011","unstructured":"Park BK, Boobis A, Clarke S, Goldring CE, Jones D, Kenna JG et al (2011) Managing the challenge of chemically reactive metabolites in drug development. Nat Rev Drug Discov 1:292\u2013306","journal-title":"Nat Rev Drug Discov"},{"key":"2183_CR4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/cphy.c120020","volume":"3","author":"ME Guicciardi","year":"2013","unstructured":"Guicciardi ME, Malhi H, Mott JL, Gores GJ (2013) Apoptosis and necrosis in the liver. Compr Physiol 3:977\u20131010","journal-title":"Compr Physiol"},{"key":"2183_CR5","first-page":"27","volume":"34","author":"P Sarges","year":"2016","unstructured":"Sarges P, Steinberg JM, Lewis JH (2016) Drug-induced liver injury: highlights from a review of the 2015 literature. Drug Saf 34:27\u201331","journal-title":"Drug Saf"},{"key":"2183_CR6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/bcp.12699","volume":"80","author":"ADB Vliegenthart","year":"2015","unstructured":"Vliegenthart ADB, Antoine DJ, Dear JW (2015) Target biomarker profile for the clinical management of paracetamol overdose: biomarkers for paracetamol-induced liver injury. Br J Clin Pharmacol 80:351\u2013362","journal-title":"Br J Clin Pharmacol"},{"key":"2183_CR7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s40291-013-0049-0","volume":"17","author":"DE Amacher","year":"2013","unstructured":"Amacher DE, Schomaker SJ, Aubrecht J (2013) Development of blood biomarkers for drug induced liver injury: an evaluation of their potential for risk assessment and diagnostics. Mol Diagn Ther 17:343\u2013354","journal-title":"Mol Diagn Ther"},{"key":"2183_CR8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","volume":"136","author":"RW Carthew","year":"2009","unstructured":"Carthew RW, Sontheimer EJ (2009) Origins and mechanisms of miRNAs and siRNAs. Cell 136:642\u2013655","journal-title":"Cell"},{"key":"2183_CR9","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2013.12.026","volume":"60","author":"A Eguchi","year":"2014","unstructured":"Eguchi A, Wree A, Feldstein AE (2014) Biomarkers of liver cell death. J Hepatol 60:1063\u20131074","journal-title":"J Hepatol"},{"key":"2183_CR10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1586\/17474124.2016.1125290","volume":"10","author":"JK DiStefano","year":"2016","unstructured":"DiStefano JK, Gerhard GS (2016) Circulating microRNAs in nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol 10:161\u2013163","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2183_CR11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281\u2013297","journal-title":"Cell"},{"key":"2183_CR12","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","volume":"108","author":"JD Arroyo","year":"2011","unstructured":"Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF et al (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 108:5003\u20135008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2183_CR13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jhep.2013.03.028","volume":"59","author":"AI Masyuk","year":"2013","unstructured":"Masyuk AI, Masyuk TV, LaRusso NF (2013) Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases. J Hepatol 59:621\u2013625","journal-title":"J Hepatol"},{"key":"2183_CR14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ncb0309-228","volume":"11","author":"J Winter","year":"2009","unstructured":"Winter J, Jung S, Keller S, Gregory RI, Diederichs S (2009) Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11:228\u2013234","journal-title":"Nat Cell Biol"},{"key":"2183_CR15","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nmeth954","volume":"3","author":"P Sethupathy","year":"2006","unstructured":"Sethupathy P, Megraw M, Hatzigeorgiou AG (2006) A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods 3:881\u2013886","journal-title":"Nat Methods"},{"key":"2183_CR16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0092-8674(03)01018-3","volume":"115","author":"BP Lewis","year":"2003","unstructured":"Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115:787\u2013798","journal-title":"Cell"},{"key":"2183_CR17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrg3198","volume":"13","author":"CC Pritchard","year":"2012","unstructured":"Pritchard CC, Cheng HH, Tewari M (2012) MicroRNA profiling: approaches and considerations. Nat Rev Genet 13:358\u2013369","journal-title":"Nat Rev Genet"},{"key":"2183_CR18","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.cell.2012.02.005","volume":"148","author":"JT Mendell","year":"2012","unstructured":"Mendell JT, Olson EN (2012) MicroRNAs in stress signaling and human disease. Cell 148:1172\u20131187","journal-title":"Cell"},{"key":"2183_CR19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/nar\/gkq1027","volume":"39","author":"A Kozomara","year":"2011","unstructured":"Kozomara A, Griffiths-Jones S (2011) miRBase: integrating microRNA annotation and deep sequencing data. Nucleic Acids Res 39:152\u2013157","journal-title":"Nucleic Acids Res"},{"key":"2183_CR20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pharmthera.2014.05.011","volume":"144","author":"P Shahabi","year":"2014","unstructured":"Shahabi P, Siest G, Meyer UA, Visvikis-Siest S (2014) Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders. Pharmacol Ther 144:134\u2013161","journal-title":"Pharmacol Ther"},{"key":"2183_CR21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.pharmthera.2007.09.004","volume":"116","author":"M Ingelman-Sundberg","year":"2007","unstructured":"Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C (2007) Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther 116:496\u2013526","journal-title":"Pharmacol Ther"},{"key":"2183_CR22","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1158\/0008-5472.CAN-06-1403","volume":"66","author":"Y Tsuchiya","year":"2006","unstructured":"Tsuchiya Y (2006) MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Res 66:9090\u20139098","journal-title":"Cancer Res"},{"key":"2183_CR23","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1096\/fasebj.6.2.1537462","volume":"6","author":"DR Koop","year":"1992","unstructured":"Koop DR (1992) Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J 6:724\u2013730","journal-title":"FASEB J"},{"key":"2183_CR24","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1124\/dmd.113.052860","volume":"41","author":"U Shukla","year":"2013","unstructured":"Shukla U, Tumma N, Gratsch T, Dombkowski A, Novak RF (2013) Insights into insulin-mediated regulation of CYP2E1: miR-132\/\u2212212 targeting of CYP2E1 and role of phosphatidylinositol 3-kinase, Akt (protein kinase B), mammalian target of rapamycin signaling in regulating miR-132\/\u2212212 and miR-122\/\u2212181a expression in primary cultured rat hepatocytes. Drug Metab Dispos 41:1769\u20131777","journal-title":"Drug Metab Dispos"},{"key":"2183_CR25","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.bbagrm.2016.02.016","volume":"1859","author":"L Miao","year":"2016","unstructured":"Miao L, Yao H, Li C, Pu M, Yao X, Yang H et al (2016) A dual inhibition: microRNA-552 suppresses both transcription and translation of cytochrome P450 2E1. Biochim Biophys Acta BBA - Gene Regul Mech 1859:650\u2013662","journal-title":"Biochim Biophys Acta BBA - Gene Regul Mech"},{"key":"2183_CR26","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1124\/dmd.115.065664","volume":"43","author":"M Nakano","year":"2015","unstructured":"Nakano M, Mohri T, Fukami T, Takamiya M, Aoki Y, McLeod HL et al (2015) Single-nucleotide polymorphisms in cytochrome P450 2E1 (CYP2E1) 3\u2032-untranslated region affect the regulation of CYP2E1 by miR-570. Drug Metab Dispos 43:1450\u20131457","journal-title":"Drug Metab Dispos"},{"key":"2183_CR27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1124\/dmd.113.052670","volume":"42","author":"M Li","year":"2013","unstructured":"Li M, Yang Y, He Z-X, Zhou Z-W, Yang T, Guo P et al (2013) MicroRNA-561 promotes acetaminophen-induced hepatotoxicity in HepG2 cells and primary human hepatocytes through downregulation of the nuclear receptor corepressor dosage-sensitive sex-reversal adrenal hypoplasia congenital critical region on the X chromosome, gene 1 (DAX-1). Drug Metab Dispos 42:44\u201361","journal-title":"Drug Metab Dispos"},{"key":"2183_CR28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tox.2015.08.012","volume":"337","author":"A Doricakova","year":"2015","unstructured":"Doricakova A, Vrzal R (2015) A food contaminant ochratoxin a suppresses pregnane X receptor (PXR)-mediated CYP3A4 induction in primary cultures of human hepatocytes. Toxicology 337:72\u201378","journal-title":"Toxicology"},{"key":"2183_CR29","doi-asserted-by":"crossref","first-page":"e0153130","DOI":"10.1371\/journal.pone.0153130","volume":"11","author":"A Sato","year":"2016","unstructured":"Sato A, Omi T, Yamamoto A, Satake A, Hiramoto A, Masutani M et al (2016) MicroRNA-351 regulates two-types of cell death, necrosis and apoptosis, induced by 5-fluoro-2\u2032-deoxyuridine. PLoS One 11:e0153130","journal-title":"PLoS One"},{"key":"2183_CR30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-4347(00)81934-9","volume":"426","author":"MC Roach","year":"1988","unstructured":"Roach MC, Gozel P, Zare RN (1988) Determination of methotrexate and its major metabolite, 7-hydroxymethotrexate, using capillary zone electrophoresis and laser-induced fluorescence detection. J Chromatogr B Biomed Sci App 426:129\u2013140","journal-title":"J Chromatogr B Biomed Sci App"},{"key":"2183_CR31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jhep.2015.02.039","volume":"62","author":"C Trautwein","year":"2015","unstructured":"Trautwein C, Friedman SL, Schuppan D, Pinzani M (2015) Hepatic fibrosis: concept to treatment. J Hepatol 62:15\u201324","journal-title":"J Hepatol"},{"key":"2183_CR32","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1053\/j.gastro.2012.06.036","volume":"143","author":"JS Troeger","year":"2012","unstructured":"Troeger JS, Mederacke I, Gwak G, Dapito DH, Mu X, Hsu CC et al (2012) Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology 143:1073\u20131083","journal-title":"Gastroenterology"},{"key":"2183_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13069-015-0031-z","volume":"8","author":"A El Taghdouini","year":"2015","unstructured":"El Taghdouini A, Najimi M, Sancho-Bru P, Sokal E, van Grunsven LA (2015) In vitro reversion of activated primary human hepatic stellate cells. Fibrogenesis Tissue Repair 8:1\u201315","journal-title":"Fibrogenesis Tissue Repair"},{"key":"2183_CR34","doi-asserted-by":"crossref","first-page":"11549","DOI":"10.1038\/srep11549","volume":"5","author":"M Coll","year":"2015","unstructured":"Coll M, Taghdouini AE, Perea L, Mannaerts I, Vila-Casades\u00fas M, Blaya D et al (2015) Integrative miRNA and gene expression profiling analysis of human quiescent hepatic stellate cells. Sci Rep 5:11549","journal-title":"Sci Rep"},{"key":"2183_CR35","doi-asserted-by":"crossref","unstructured":"Mannaerts I, Schroyen B, Verhulst S, Van Lommel L, Schuit F, Nyssen M, et al. (2013). Gene expression profiling of early hepatic stellate cell activation reveals a role for Igfbp3 in cell migration. PLoS ONE e84071","DOI":"10.1371\/journal.pone.0084071"},{"key":"2183_CR36","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1172\/JCI118304","volume":"96","author":"KS Lee","year":"1995","unstructured":"Lee KS, Buck M, Houglum K, Chojkier M (1995) Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 96:2461\u20132468","journal-title":"J Clin Invest"},{"key":"2183_CR37","doi-asserted-by":"crossref","first-page":"11351","DOI":"10.1074\/jbc.M212291200","volume":"278","author":"HO Hambrock","year":"2003","unstructured":"Hambrock HO, Nitsche DP, Hansen U, Bruckner P, Paulsson M, Maurer P et al (2003) SC1\/hevin. An extracellular calcium-modulated protein that binds collagen. I J Biol Chem 278:11351\u201311358","journal-title":"I J Biol Chem"},{"key":"2183_CR38","doi-asserted-by":"crossref","first-page":"27621","DOI":"10.1074\/jbc.M510507200","volume":"281","author":"MM Sullivan","year":"2006","unstructured":"Sullivan MM, Barker TH, Funk SE, Karchin A, Seo NS, H\u00f6\u00f6k M et al (2006) Matricellular hevin regulates decorin production and collagen assembly. J Biol Chem 281:27621\u201327632","journal-title":"J Biol Chem"},{"key":"2183_CR39","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2012.11.022","volume":"58","author":"C Roderburg","year":"2013","unstructured":"Roderburg C, Luedde M, Cardenas DV, Vucur M, Mollnow T, Zimmermann HW et al (2013) miR-133a mediates TGF-\u03b2-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. J Hepatol 58:736\u2013742","journal-title":"J Hepatol"},{"key":"2183_CR40","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jhep.2012.11.011","volume":"58","author":"J Li","year":"2013","unstructured":"Li J, Ghazwani M, Zhang Y, Lu J, Li J, Fan J et al (2013) miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression. J Hepatol 58:522\u2013528","journal-title":"J Hepatol"},{"key":"2183_CR41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2012.09.024","volume":"58","author":"A Noetel","year":"2013","unstructured":"Noetel A, Elfimova N, Altm\u00fcller J, Becker C, Becker D, Lahr W et al (2013) Next generation sequencing of the Ago2 interacting transcriptome identified chemokine family members as novel targets of neuronal microRNAs in hepatic stellate cells. J Hepatol 58:335\u2013341","journal-title":"J Hepatol"},{"key":"2183_CR42","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1021\/acs.chemrestox.6b00098","volume":"29","author":"YM Koen","year":"2016","unstructured":"Koen YM, Galeva NA, Metushi IG, Uetrecht J, Hanzlik RP (2016) Protein targets of isoniazid-reactive metabolites in mouse liver in Vivo. Chem Res Toxicol 29:1064\u20131072","journal-title":"Chem Res Toxicol"},{"key":"2183_CR43","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1038\/srep11590","volume":"5","author":"V Benes","year":"2015","unstructured":"Benes V, Collier P, Kordes C, Stolte J, Rausch T, Muckentaler MU et al (2015) Identification of cytokine-induced modulation of microRNA expression and secretion as measured by a novel microRNA specific qPCR assay. Sci Rep 5:11590","journal-title":"Sci Rep"},{"key":"2183_CR44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.gene.2016.03.008","volume":"584","author":"S Ghosh","year":"2016","unstructured":"Ghosh S, Dass JFP (2016) Study of pathway cross-talk interactions with NF-\u03baB leading to its activation via ubiquitination or phosphorylation: a brief review. Gene 584:97\u2013109","journal-title":"Gene"},{"key":"2183_CR45","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jhep.2011.11.017","volume":"56","author":"C Scisciani","year":"2012","unstructured":"Scisciani C, Vossio S, Guerrieri F, Schinzari V, De Iaco R, de Meo PD et al (2012) Transcriptional regulation of miR-224 upregulated in human HCCs by NF\u03baB inflammatory pathways. J Hepatol 56:855\u2013861","journal-title":"J Hepatol"},{"key":"2183_CR46","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.3748\/wjg.v22.i15.3907","volume":"22","author":"S Fiorino","year":"2016","unstructured":"Fiorino S, Bacchi-Reggiani ML, Visani M, Acquaviva G, Fornelli A, Masetti M et al (2016) MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma. World J Gastroenterol 22:3907","journal-title":"World J Gastroenterol"},{"key":"2183_CR47","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1038\/srep09991","volume":"5","author":"F Momen-Heravi","year":"2015","unstructured":"Momen-Heravi F, Bala S, Kodys K, Szabo G (2015) Exosomes derived from alcohol-treated hepatocytes horizontally transfer liver specific miRNA-122 and sensitize monocytes to LPS. Sci Rep 5:9991","journal-title":"Sci Rep"},{"key":"2183_CR48","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1373\/clinchem.2010.147850","volume":"1","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y, Guo H et al (2010) Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 1:1830\u20131838","journal-title":"Clin Chem"},{"key":"2183_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-015-0623-9","volume":"13","author":"F Momen-Heravi","year":"2015","unstructured":"Momen-Heravi F, Saha B, Kodys K, Catalano D, Satishchandran A, Szabo G (2015) Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis. J Transl Med 13:1","journal-title":"J Transl Med"},{"key":"2183_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17060961","author":"J Hyun","year":"2016","unstructured":"Hyun J, Park J, Wang S, Kim J, Lee H-H, Seo Y-S et al (2016) MicroRNA expression profiling in CCl4-induced liver fibrosis of Mus musculus. Int J Mol Sci. doi: 10.3390\/ijms17060961","journal-title":"Int J Mol Sci"},{"key":"2183_CR51","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","volume":"1","author":"H Valadi","year":"2007","unstructured":"Valadi H (2007) Ekstro\u00a8m\u00a0K, Bossios a, Sj\u00f6strand M, lee JJ, L\u00f6tvall JO (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 1:654\u2013659","journal-title":"Nat Cell Biol"},{"key":"2183_CR52","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/hep.26294","volume":"1","author":"DJ Antoine","year":"2013","unstructured":"Antoine DJ, Dear JW, Lewis PS, Platt V, Coyle J, Masson M et al (2013) Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology 1:777\u2013787","journal-title":"Hepatology"},{"key":"2183_CR53","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12730","author":"Y Murakami","year":"2016","unstructured":"Murakami Y, Kawada N (2016) MicroRNAs in hepatic pathophysiology: MicroRNA in the liver. Hepatol Res. doi: 10.1111\/hepr.12730","journal-title":"Hepatol Res"},{"key":"2183_CR54","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/jcm5050052","volume":"5","author":"A Mahgoub","year":"2016","unstructured":"Mahgoub A, Steer C (2016) MicroRNAs in the evaluation and potential treatment of liver diseases. J Clin Med 5:52","journal-title":"J Clin Med"},{"key":"2183_CR55","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1073\/pnas.0813371106","volume":"1","author":"K Wang","year":"2009","unstructured":"Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z et al (2009) Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A 1:4402\u20134407","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2183_CR56","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.24538","volume":"1","author":"PJ Starkey-Lewis","year":"2011","unstructured":"Starkey-Lewis PJ, Dear J, Platt V, Simpson KJ, Craig DG, Antoine DJ et al (2011) Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 1:1767\u20131776","journal-title":"Hepatology"},{"key":"2183_CR57","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/toxsci\/kfu232","volume":"143","author":"J Krauskopf","year":"2015","unstructured":"Krauskopf J, Caiment F, Claessen SM, Johnson KJ, Warner RL, Schomaker SJ et al (2015) Application of high-throughput sequencing to circulating microRNAs reveals novel biomarkers for drug-induced liver injury. Toxicol Sci 143:268\u2013276","journal-title":"Toxicol Sci"},{"key":"2183_CR58","doi-asserted-by":"crossref","first-page":"15501","DOI":"10.1038\/srep15501","volume":"5","author":"ADB Vliegenthart","year":"2015","unstructured":"Vliegenthart ADB, Shaffer JM, Clarke JI, Peeters LEJ, Caporali A, Bateman DN et al (2015) Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury. Sci Rep 5:15501","journal-title":"Sci Rep"},{"key":"2183_CR59","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jhep.2008.01.019","volume":"1","author":"M Girard","year":"2008","unstructured":"Girard M, Jacquemin E, Munnich A, Lyonnet S, Henrion-Caude A (2008) miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol 1:648\u2013656","journal-title":"J Hepatol"},{"key":"2183_CR60","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1172\/JCI63539","volume":"122","author":"H S-h","year":"2012","unstructured":"S-h H, Wang B, Kota J, Yu J, Costinean S, Kutay H et al (2012) Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest 122:2871","journal-title":"J Clin Invest"},{"key":"2183_CR61","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/1354750X.2015.1101785","volume":"20","author":"JM Falcon-Perez","year":"2015","unstructured":"Falcon-Perez JM, Royo F (2015) Circulating RNA: looking at the liver through a frosted glass. Biomarkers 20:339\u2013354","journal-title":"Biomarkers"},{"key":"2183_CR62","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/liv.12322","volume":"34","author":"P Thulin","year":"2014","unstructured":"Thulin P, Nordahl G, Gry M, Yimer G, Aklillu E, Makonnen E et al (2014) Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts. Liver Int 34:367\u2013378","journal-title":"Liver Int"},{"key":"2183_CR63","doi-asserted-by":"crossref","first-page":"12169","DOI":"10.1073\/pnas.1412608111","volume":"111","author":"J Ward","year":"2014","unstructured":"Ward J, Kanchagar C, Veksler-Lublinsky I, Lee RC, McGill MR, Jaeschke H et al (2014) Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis. Proc Natl Acad Sci 111:12169\u201312174","journal-title":"Proc Natl Acad Sci"},{"key":"2183_CR64","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/toxsci\/kfu269","volume":"144","author":"R Kia","year":"2015","unstructured":"Kia R, Kelly L, Sison-Young RLC, Zhang F, Pridgeon CS, Heslop JA et al (2015) MicroRNA-122: a novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity. Toxicol Sci 144:173\u2013185","journal-title":"Toxicol Sci"},{"key":"2183_CR65","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.taap.2015.02.013","volume":"284","author":"X Yang","year":"2015","unstructured":"Yang X, Salminen WF, Shi Q, Greenhaw J, Gill PS, Bhattacharyya S et al (2015) Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children. Toxicol Appl Pharmacol 284:180\u2013187","journal-title":"Toxicol Appl Pharmacol"},{"key":"2183_CR66","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.4172\/2153-0769.1000101","volume":"1","author":"X Yang","year":"2011","unstructured":"Yang X, Li Z, Su Z, Davis K, Chen T, Mendrick DL et al (2011) Urinary microRNAs as noninvasive biomarkers for acetaminophen-induced liver injury. J Postgenom Drug Biomark Develop 1:2153\u20130769.1000101","journal-title":"J Postgenom Drug Biomark Develop"},{"key":"2183_CR67","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/hep.25873","volume":"1","author":"S Bala","year":"2012","unstructured":"Bala S, Petrasek J, Mundkur S, Catalano D, Levin I, Ward J et al (2012) Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 1:1946\u20131957","journal-title":"Hepatology"},{"key":"2183_CR68","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.toxlet.2014.01.013","volume":"225","author":"X Yang","year":"2014","unstructured":"Yang X, Weng Z, Mendrick DL, Shi Q (2014) Circulating extracellular vesicles as a potential source of new biomarkers of drug induced liver injury. Toxicol Lett 225:401\u2013406","journal-title":"Toxicol Lett"},{"key":"2183_CR69","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","volume":"1","author":"KC Vickers","year":"2011","unstructured":"Vickers KC, Palmisano BT, Shoucri BM et al (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 1:423\u2013433","journal-title":"Nat Cell Biol"},{"key":"2183_CR70","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/prca.200900103","volume":"1","author":"J Conde-Vancells","year":"2010","unstructured":"Conde-Vancells J, Rodriguez-Suarez E, Gonzalez E, Berisa A, Gil D, Embade N et al (2010) Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples. Proteomics Clin Appl 1:416\u2013425","journal-title":"Proteomics Clin Appl"},{"key":"2183_CR71","doi-asserted-by":"crossref","first-page":"13368","DOI":"10.1073\/pnas.0403453101","volume":"1","author":"T Pisitkun","year":"2004","unstructured":"Pisitkun T, Shen R-F, Knepper MA (2004) Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 1:13368\u201313373","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"sup1","key":"2183_CR72","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1517\/14712598.2012.680018","volume":"12","author":"C L\u00e4sser","year":"2012","unstructured":"L\u00e4sser C (2012) Exosomal RNA as biomarkers and the therapeutic potential of exosome vectors. Expert Opin Biol Ther 12(sup1):S189\u2013S197","journal-title":"Expert Opin Biol Ther"},{"key":"2183_CR73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MOL.0b013e328350a425","volume":"23","author":"KC Vickers","year":"2012","unstructured":"Vickers KC, Remaley AT (2012) Lipid-based carriers of microRNAs and intercellular communication. Curr Opin Lipidol 23:91\u201397","journal-title":"Curr Opin Lipidol"},{"key":"2183_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/731479","volume":"2015","author":"P Tiberio","year":"2015","unstructured":"Tiberio P, Callari M, Angeloni V, Daidone MG, Appierto V (2015) Challenges in using circulating miRNAs as cancer biomarkers. Biomed Res Int 2015:1\u201310","journal-title":"Biomed Res Int"},{"key":"2183_CR75","unstructured":"Drug interactions & labeling\u2014drug development and drug interactions: table of substrates, inhibitors and inducers [Internet]. [cited 2016 Aug 2]. Available from: http:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources \/DrugInteractionsLabeling\/ucm093664.htm"},{"key":"2183_CR76","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.lfs.2014.03.031","volume":"103","author":"MD Chanyshev","year":"2014","unstructured":"Chanyshev MD, Kosorotikov NI, Titov SE, Kolesnikov NN, Gulyaeva LF (2014) Expression of microRNAs, CYP1A1 and CYP2B1 in the livers and ovaries of female rats treated with DDT and PAHs. Life Sci 103:95\u2013100","journal-title":"Life Sci"},{"key":"2183_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2014.00167","author":"M Swart","year":"2014","unstructured":"Swart M, Dandara C (2014) Genetic variation in the 3\u2032-UTR of CYP1A2, CYP2B6, CYP2D6, CYP3A4, NR1I2, and UGT2B7: potential effects on regulation by microRNA and pharmacogenomics relevance. Front Genet doi. doi: 10.3389\/fgene.2014.00167","journal-title":"Front Genet doi"},{"key":"2183_CR78","doi-asserted-by":"crossref","first-page":"12932","DOI":"10.1074\/jbc.M113.452953","volume":"288","author":"AA Walsh","year":"2013","unstructured":"Walsh AA, Szklarz GD, Scott EE (2013) Human cytochrome P4501A1 structure and utility in understanding drug and xenobiotic metabolism. J Biol Chem 288:12932\u201312943","journal-title":"J Biol Chem"},{"key":"2183_CR79","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.tox.2013.06.006","volume":"311","author":"D Simic","year":"2013","unstructured":"Simic D, Euler C, Haines E, He A, Peden WM, Bunch RT et al (2013) MicroRNA changes associated with atypical CYP1A1 inducer BMS-764459. Toxicology 311:169\u2013177","journal-title":"Toxicology"},{"key":"2183_CR80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfr168","volume":"123","author":"T Yokoi","year":"2011","unstructured":"Yokoi T, Nakajima M (2011) Toxicological implications of modulation of gene expression by microRNAs. Toxicol Sci 123:1\u201314","journal-title":"Toxicol Sci"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-016-2183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-016-2183-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-016-2183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T01:34:05Z","timestamp":1658280845000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-016-2183-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,27]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["2183"],"URL":"https:\/\/doi.org\/10.1007\/s00228-016-2183-1","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,27]]}}}